News
-
-
-
PRESS RELEASE
Moderna Reports Second Quarter 2025 Financial Results and Provides Business Updates
Moderna reports Q2 revenue of $0.1B, net loss of $(0.8)B, updates 2025 revenue to $1.5-$2.2B due to shipment timing, improves operating expenses by $400M, reiterates $6B year-end cash balance. FDA approvals for flu vaccine -
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Press release on total number of voting rights and shares as of 31 July 2025 in accordance with French commercial code and Financial Markets Authority regulations -
-
-
PRESS RELEASE
aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
aap Implantate AG announces full admission of previously unadmitted shares to the Frankfurt Stock Exchange's regulated market, along with the termination of lock-up agreements -
